| Clinical advances in the development of novel VEGFR2 inhibitors C Fontanella, E Ongaro, S Bolzonello, M Guardascione, G Fasola, ... Annals of translational medicine 2 (12), 2014 | 276 | 2014 |
| Impact of body mass index on neoadjuvant treatment outcome: a pooled analysis of eight prospective neoadjuvant breast cancer trials C Fontanella, B Lederer, S Gade, M Vanoppen, JU Blohmer, SD Costa, ... Breast cancer research and treatment 150, 127-139, 2015 | 118 | 2015 |
| Management of breast cancer patients with chemotherapy-induced neutropenia or febrile neutropenia C Fontanella, S Bolzonello, B Lederer, G Aprile Breast care 9 (4), 239-245, 2014 | 70 | 2014 |
| Current challenges in HER2-positive breast cancer F Puglisi, C Fontanella, V Amoroso, GV Bianchi, G Bisagni, C Falci, ... Critical Reviews in Oncology/Hematology 98, 211-221, 2016 | 59 | 2016 |
| Ramucirumab: preclinical research and clinical development G Aprile, E Rijavec, C Fontanella, K Rihawi, F Grossi OncoTargets and therapy, 1997-2006, 2014 | 57 | 2014 |
| Skeletal metastases from breast cancer: pathogenesis of bone tropism and treatment strategy C Fontanella, V Fanotto, K Rihawi, G Aprile, F Puglisi Clinical & experimental metastasis 32, 819-833, 2015 | 54 | 2015 |
| Prognostic factors in 868 advanced gastric cancer patients treated with second-line chemotherapy in the real world V Fanotto, S Cordio, G Pasquini, C Fontanella, L Rimassa, F Leone, ... Gastric Cancer 20, 825-833, 2017 | 49 | 2017 |
| Follow-up of patients with early breast cancer: is it time to rewrite the story? F Puglisi, C Fontanella, G Numico, V Sini, L Evangelista, F Monetti, S Gori, ... Critical reviews in oncology/hematology 91 (2), 130-141, 2014 | 45 | 2014 |
| Risk factors and survival outcomes in patients with brain metastases from breast cancer AM Minisini, S Moroso, L Gerratana, M Giangreco, D Iacono, E Poletto, ... Clinical & experimental metastasis 30, 951-956, 2013 | 45 | 2013 |
| Selecting the neoadjuvant treatment by molecular subtype: how to maximize the benefit? G von Minckwitz, C Fontanella The Breast 22, S149-S151, 2013 | 45 | 2013 |
| Human papillomavirus (HPV) persistence and HPV 31 predict the risk of recurrence in high-grade vaginal intraepithelial neoplasia G Bogani, F Martinelli, A Ditto, F Taverna, C Lombardo, M Signorelli, ... European Journal of Obstetrics & Gynecology and Reproductive Biology 210 …, 2017 | 41 | 2017 |
| A new nomogram for estimating survival in patients with brain metastases secondary to colorectal cancer F Pietrantonio, G Aprile, L Rimassa, P Franco, S Lonardi, C Cremolini, ... Radiotherapy and Oncology 117 (2), 315-321, 2015 | 40 | 2015 |
| Capecitabine-induced cardiotoxicity: more evidence or clinical approaches to protect the patients’ heart? C Fontanella, M Aita, M Cinausero, G Aprile, MG Baldin, V Dusi, ... OncoTargets and therapy, 1783-1791, 2014 | 35 | 2014 |
| Post-neoadjuvant strategies in breast cancer: From risk assessment to treatment escalation G Pelizzari, L Gerratana, D Basile, V Fanotto, M Bartoletti, A Liguori, ... Cancer Treatment Reviews 72, 7-14, 2019 | 29 | 2019 |
| HER-2 expression in brain metastases from colorectal cancer and corresponding primary tumors: a case cohort series G Aprile, G De Maglio, J Menis, M Casagrande, F Tuniz, FE Pisa, ... International Journal of Molecular Sciences 14 (2), 2370-2387, 2013 | 24 | 2013 |
| Central nervous system involvement in breast cancer patients: Is the therapeutic landscape changing too slowly? C Fontanella, E De Carlo, M Cinausero, G Pelizzari, I Venuti, F Puglisi Cancer Treatment Reviews 46, 80-88, 2016 | 23 | 2016 |
| Eribulin in the treatment of advanced breast cancer: real-world scenario from 39 Italian centers–ESEMPiO study S Barni, L Livraghi, M Morritti, P Vici, A Michelotti, S Cinieri, C Fontanella, ... Future Oncology 15 (1), 33-44, 2018 | 20 | 2018 |
| Health-related quality of life in breast cancer patients treated with CDK4/6 inhibitors: a systematic review V Di Lauro, G Barchiesi, F Martorana, G Zucchini, M Muratore, ... ESMO open 7 (6), 100629, 2022 | 19 | 2022 |
| MGMT Promoter Methylation Status in Brain Metastases from Colorectal Cancer and Corresponding Primary Tumors GD Maglio, M Casagrande, M Guardascione, C Fontanella, SE Lutrino, ... Future Oncology 11 (8), 1201-1209, 2015 | 18 | 2015 |
| Timing and extent of response in colorectal cancer: critical review of current data and implication for future trials G Aprile, C Fontanella, M Bonotto, K Rihawi, SE Lutrino, L Ferrari, ... Oncotarget 6 (30), 28716, 2015 | 17 | 2015 |
Giuseppe AprileDepartment of Oncology, Vicenza, Italy在 aulss8.veneto.it 的电子邮件经过验证
